期刊文献+

^(99)Tc-MDP对类风湿性关节炎患者外周血单核细胞产生细胞因子的影响 被引量:15

Effect of ^(99)Tc-MDP on cytokine production by peripheral blood mononuclear cells of patients with rheumatoid arthritis
下载PDF
导出
摘要 目的 :探讨“云克”(99Tc MDP)治疗类风湿性关节炎 (RA)的免疫机制。方法 :采用ELISA双抗体夹心法 ,观察“云克”体外对RA患者外周血单核细胞 (PBMC)产生白介素 1(IL 1)和可溶性白介素 2受体 (sIL 2R)的影响。结果 :“云克”有抑制RA患者IL 1的分泌及细菌脂多糖 (LPS)的促分泌作用 ,并对可溶性白介素 2受体的自发分泌及植物血素 (PHA)诱导分泌均有抑制作用。结论 :“云克”对RA的治疗机制可能与其降低IL 1和sIL Objective To study the immune mechanism of 99 Tc MDP in the treatment of patients with rheumatoid arthritis (RA). Methods In vitro, 99 Tc MDP was added to the cultures of peripheral blood mononuclear cells (PBMC) derived from healthy subjects and RA patients. The levels of IL 1 and sIL 2R from PBMC affected by 99 Tc MDP were determined with enzyme linked immunosorbert assays (ELISA). Results The IL 1 production by PBMC of RA, either in the medium alone (spontaneously) or in the presence of lipopolysacchride (LPS) stimulation, was suppressed by 99 Tc MDP; and the sIL 2R by PBMC of RA, either in the medium alone (spontaneously) or in the presence of phytohemagglutinin (PHA) induction, was inhibited by 99 Tc MDP. Conclusion 99 Tc MDP acts on PBMC and a possible immune activity by 99 Tc MDP is related to the suppression of IL 1 and sIL 2R in RA patients.
出处 《湖南医科大学学报》 CSCD 北大核心 2002年第2期173-175,共3页 Bulletin of Hunan Medical University
关键词 ^99TC-MDP 类风湿性关节炎 外周血 单核细胞 细胞因子 影响 白细胞介素1 细胞介素-2 受体 arthritis,rheumatoid 99 Tc MDP * interleukin 1 interleukin 2 receptors
  • 相关文献

参考文献6

  • 1蒋宁一,梁九根,卢献平,刘生,钟飞燕,邬敬平.云克(^(99)Tc-MDP)治疗类风湿关节炎的疗效分析[J].现代临床医学生物工程学杂志,2000,6(3):180-182. 被引量:41
  • 2Kaly WA. Rheumatic disease diagnose and management[M].Philadelphla:LiPPihcoll Co,1987.446.
  • 3Chang DM, Weinblaff ME, Schur PH. et al. The effects of methotrexate on interleukin 1 in patients with rheumatoid arthritis[J].J Rheumatol, 1992, 19:1678-1682.
  • 4Buchan G, Barretl K, Turner M, et al. Interleukin-1 and tumor necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha[J]. Clin Exp Immunol, 1988,73:449-455.
  • 5Symons J, Wood NC, Di Giovine FS, et al. Soluble IL-2 receptor in rheumatoid arthritis: Correlation with disease activity, IL-2 and IL-2 inhibition[J]. J Immunol, 1988,141:2612-2618.
  • 6Rubin LA, Nelson DL. The soluable interleukin-2 receptor: biology, function and clinical application[J]. Ann Intern Med, 1990, 113:619-627.

二级参考文献3

  • 11,MazzettiI,GrigoloB,BorziRM,etal.Serumcopper/zincsuperoxidedismutaselevelsinpatientswithrheumatoidarthritis[J].IntJClinLaborRes,1996,26(4):245
  • 22,HessEV.In:SchumacherHR(ed).Primeronrheumaticdiseases[M].9thed,America:AtlantaArthitisFoundation,1988,93
  • 33,KremerJM.Thechangingfaceoftherapyforrheumatoidarthritis[J].RheumDisClinNorthAm,1995,21(3):845

共引文献40

同被引文献98

引证文献15

二级引证文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部